A Human Mass Balance and Metabolism Study of [ 14 C]‐Ubrogepant in Healthy Male Adults

Documenti analoghi

• A 2‐Part, Open‐Label, Phase 1 Bioequivalence and Food‐Effect Study of Ubrogepant in Healthy Adult Participants
  di: Ramesh Boinpally, et al.
  Pubblicazione: (2025)
• Mass Balance and Metabolism of 14 C ‐Atogepant in Healthy Male Participants: Findings of a Phase 1 Clinical Trial
  di: Ramesh R. Boinpally, et al.
  Pubblicazione: (2025)
• Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study
  di: Ramesh Boinpally, et al.
  Pubblicazione: (2024)
• Effect of a High‐Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant Tablet
  di: Ramesh R. Boinpally, et al.
  Pubblicazione: (2024)
• Ubrogepant: Mechanism of action, clinical and translational science
  di: Ramesh Boinpally, et al.
  Pubblicazione: (2024)